Search Results
Apr 14, 2026, 07:30 ET Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers
below 10%.A recent publication from Tel Aviv University (TAU) identified a causal link between p53 inactivation and upregulation of SCD1 as essential for the proliferation of brain-metastasizing cells. The collaboration agreement with Ramot at Tel Aviv University Ltd. - TAU's technology transfer
More news about: Galmed Pharmaceuticals Ltd.
Apr 14, 2026, 07:30 ET Full Truck Alliance Co. Ltd. Files 2025 Annual Report on Form 20-F
CommunicationsJenny CaiTel: +86-10-6508-0677E-mail: [email protected] the United States:Piacente Financial CommunicationsBrandi PiacenteTel: +1-212-481-2050E-mail:
More news about: Full Truck Alliance Co. Ltd.
Apr 14, 2026, 07:18 ET i4E launched as new global technology platform
Media ContactsGilliane PalmerTel: +31 [email protected]
More news about: i4E
Apr 14, 2026, 07:15 ET i4E launched as new global technology platform
Media ContactsGilliane PalmerTel: +31 [email protected]
More news about: i4E
Apr 14, 2026, 06:10 ET CAMTEK ANNOUNCES ACQUISITION OF VISUAL LAYER TO DEEPEN ITS VISUAL AI CAPABILITIES IN ITS INSPECTION AND METROLOGY OFFERING
Eisenberg, CFOTel: +972 4 604 8308Mobile: +972 54 900 [email protected] INTERNATIONAL INVESTOR RELATIONSEK Global Investor RelationsEhud HelftTel: (US) 1 212 378 8040
More news about: Camtek Ltd.
Apr 14, 2026, 06:05 ET Valmet to publish its Interim Review for January - March 2026 on April 28, 2026
Further information, please contact:Pekka Rouhiainen, VP, Investor Relations, Valmet, tel. +358 10 672 0020 For media: Antti Ylitalo, Director, External Communications, Valmet, tel. +358 10 672 0000Valmet is a global technology leader in serving process industries. We work
More news about: Valmet Oyj
Apr 13, 2026, 19:39 ET CIGL Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit
Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Apr 13, 2026, 19:34 ET PYPL Investors Have Opportunity to Lead PayPal Holdings, Inc. Securities Fraud Lawsuit
Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Apr 13, 2026, 19:31 ET CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Apr 13, 2026, 16:30 ET Boqii to Hold Annual General Meeting on May 6, 2026
under applicable law.For investor and media inquiries, please contact:Boqii Holding LimitedInvestor RelationsTel: +86-21-6882-6051 Email: [email protected]
More news about: Boqii Holding Limited
Apr 13, 2026, 15:22 ET Rosen Law Firm Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Apr 13, 2026, 15:17 ET Rosen Law Firm Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation - DNOW
Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Apr 13, 2026, 11:00 ET How Sleep Biomarkers Improve Clinical Development and Clinical Assessment in Depression, Upcoming Webinar Hosted by Xtalks
https://xtalks.com/partner-with-us/Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]
More news about: Xtalks
Apr 13, 2026, 10:00 ET Las víctimas de fraude de OneCoin entre 2014 y 2019 pueden ser elegibles para recibir una compensación
www.onecoinremission.com Tel.: 1-833-421-9748Email: [email protected]
More news about: US Department of Justice
Apr 13, 2026, 09:00 ET L'étude DOORwaY90 de Sirtex Medical démontre un contrôle local de la tumeur de 100 % avec SIR-Spheres®, établissant ainsi une nouvelle référence pour l'Y-90 dans le traitement du CHC
atteint ses objectifs co-primaires préspécifiés, démontrant un taux de réponse complète (CR) de 90 % et un meilleur taux de réponse globale (ORR) de 99 %, tel qu'évalué par une revue centrale indépendante en aveugle. Tous les patients évaluables ont répondu au traitement, ce qui a permis d'obtenir un contrôle
More news about: Sirtex Medical Inc.
Apr 13, 2026, 08:30 ET Use Profiling Data to Reduce PROTACs and RIPTACs Program Delays, Upcoming Webinar Hosted by Xtalks
https://xtalks.com/partner-with-us/Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]
More news about: Xtalks
Apr 13, 2026, 08:30 ET Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology, Upcoming Webinar Hosted by Xtalks
https://xtalks.com/partner-with-us/Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]
More news about: Xtalks
Apr 13, 2026, 08:30 ET Vuzix to Showcase Its New Pick & Pack Validation Program at MODEX 2026 to Accelerate Warehouse Deployment
Relations, Vuzix Corporation [email protected] Tel: (585) 359-5985 Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA, Investor Information –
More news about: Vuzix Corporation
Apr 13, 2026, 08:00 ET Bladex's First Quarter 2026 Conference Call
– Chief Investor Relations OfficerE-mail address: [email protected]Tel: +507 210-8563
More news about: Bladex
Apr 13, 2026, 08:00 ET Nova to Report First Quarter 2026 Financial Results on May 14
update the forward-looking information contained in this press release.Company Contact:Guy Kizner, Chief Financial OfficerTel: +972-73-229-5760E-mail - [email protected]
More news about: Nova
Apr 13, 2026, 08:00 ET Lufax Announces Changes in Board and Committee Composition
LtdEmail: [email protected] ICR, LLCRobin YangTel: +1 (646) 308-0546Email: [email protected]
More news about: Lufax Holding Ltd
Apr 13, 2026, 07:00 ET POM Deadline: POM Investors with Losses in Excess of $100K Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit
Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Apr 13, 2026, 07:00 ET CollPlant Issues Letter to Shareholders
statements, whether as a result of new information, future events or otherwise.Contacts:Eran RotemDeputy CEO & CFOTel: + 972-73-2325600Email: [email protected]:
More news about: CollPlant
Apr 13, 2026, 06:00 ET Cango's HPC and AI Inference Subsidiary, EcoHash, Begins Commercial Operations
CommunicationsCango Inc.Email: [email protected] AdvisoryTel: +852 2117 0861Email: [email protected]
More news about: Cango Inc.
Apr 13, 2026, 05:30 ET Weibo to Hold Annual General Meeting on May 27, 2026
update such information, except as required under applicable law.ContactsInvestors RelationsWeibo CorporationTel: +86-10-5898-3336Email: [email protected]
More news about: Weibo Corporation